Merck and Bayer announced the US FDA approval for Verquvo Merck and Bayer have announced that the companies have received the US FDA's approval for Verquvo (vericiguat). The drug is approved for ...
Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients Biogen has announced that the first patient with spinal muscular atrophy (SMA) has been treated with Spinraza (nusinersen), who were prio...
Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile Johnson and Johnson announced that it will acquire Momenta Pharmaceuticals for an all cash transaction worth of $6.5 billion. Momenta Pha...
US FDA approved another drug for rare Duchenne Muscular Dystrophy The United States Food and Drug Administration has approved Viltepso (viltolarsen) for treating patients suffering from Duchenne muscular...
Gilead submitted NDA for Veklury to treat COVID-19 in the US Gilead has submitted a New Drug Application (NDA) for Veklury (remdesivir) to the Food and Drug Administration (FDA) for treating patient...
Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients Biogen has announced that the first patient with spinal muscular atrophy (SMA) has been treated with Spinraza (nusinersen), who were prio...
Kite’s CAR-Tcell therapy received approval in Europe for relapsed or refractory mantle cell lymphoma Kite announced that it received conditional approval in Europe for Tecartus (brexucabtagene autoleucel). Tecartus is a chimeric antigen r...
Lynparza was approved for three more indications in Japan AstraZeneca and Merck announced that Lynparza (olaparib) was approved for three more indications in Japan. The three new cancer indicatio...
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients Gilead has announced top-line Phase 3 trial results of remdesivir in patients with COVID-19. The drug is indicated in moderate COVID-19 p...
Astellas received approval for Xtandi in Japan for prostate cancer Astellas announced that it had received approval from Japan Ministry of Health, Labour and Welfare (MHLW) for Xtandi (enzalutamide) for t...
Gilead’s Veklury (remdesivir) approved by Japan’s MHLW for COVID-19 Gilead has announced that the Japanese Ministry of Health, Labor and Welfare approved Veklury (remdesivir) for severe COVID-19. The drug ...
TGA approved Novartis Luxturna in Australia Australian Therapeutic Goods Administration has approved Luxturna (voretigene neparvovec) for treating patients with inherited retinal dy...
Roche’s Rozlytrek approved in Australia for ROS1 positive NSCLC Australia’s Therapeutic Goods Administration has approved Rozlytrek (entrectinib) for treating patients suffering from ROS1 positive non-...
ipharmaservices Jan 12 1 min Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
ipharmaservices Aug 25, 2020 2 min Merck’s Keytruda received one more indication and dosage form approval in Japan
ipharmaservices Aug 22, 2020 2 min AZ received one more approval in Japan, received approval of Imfinzi for SCLC
